GMED241115P90000
- 9.34
- 0.000.00%
Globus Medical Newsroom
Morgan Stanley Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $83
Globus Medical Is Maintained at Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Express News | Globus Medical Inc : Morgan Stanley Raises Target Price to $83 From $74
Globus Medical(GMED.US) Officer Sells US$4.8 Million in Common Stock
$Globus Medical(GMED.US)$ Officer Scavilla Daniel T sold 60,000 shares of common stock on Nov 6, 2024 at an average price of $80.02 for a total value of $4.8 million.Source: Announcement What is
Globus Medical Insider Sold Shares Worth $4,801,200, According to a Recent SEC Filing
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Stifel Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
Globus Medical, Inc. Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Form 144 | Globus Medical(GMED.US) Officer Proposes to Sell 4.8 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 6, $Globus Medical(GMED.US)$ Officer Scavilla Daniel T intends to sell 60,000 shares of its common stock on Nov 6, with a total market value of approximately $4.8 million.
Roth MKM Reiterates Buy on Globus Medical, Maintains $100 Price Target
What 7 Analyst Ratings Have To Say About Globus Medical
Earnings Call: Globus Medical Reports Robust Q3 Growth, Eyes 2025 Prospects
Globus Medical Is Maintained at Overweight by Piper Sandler
Globus Medical Price Target Raised to $100.00/Share From $80.00 by Piper Sandler
B of A Securities Maintains Underperform on Globus Medical, Raises Price Target to $80
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $85 to $100
Cautious Outlook on Globus Medical Amid Growth Concerns and Competitive Challenges
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Globus Medical's Strong Q3 Performance and Optimistic Outlook Justify Buy Rating